$KWR
QUAKER CHEMICAL CORP Stock $kwr

$kwr Overview Financials Valuation SEC Filings Company Website

2021 Q1 Form 10-Q Financial Statement

#000008136221000008 Filed on May 06, 2021

Income Statement

Concept	2021 Q1	2020 Q1
Revenue	$429.8M	$378.6M
YoY Change	13.53%	79.23%
Cost Of Revenue	$273.6M	$244.7M
YoY Change	11.8%	80.67%
Gross Profit	$156.2M	$133.9M
YoY Change	16.69%	76.66%
Gross Profit Margin	36.34%	35.36%
Selling, General & Admin	$104.3M	$98.70M
YoY Change	5.68%	91.82%
% of Gross Profit	66.78%	73.74%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$22.15M	$21.20M
YoY Change	4.47%	336.24%
% of Gross Profit	14.18%	15.84%
Operating Expenses	$104.3M	$98.70M
YoY Change	5.68%	91.82%
Operating Profit	$44.89M	-$12.44M
YoY Change	-460.77%	-162.76%
Interest Expense	$5.837M	$8.899M
YoY Change	-34.41%	633.03%
% of Operating Profit	13.0%
Other Income/Expense, Net	$4.687M	-$21.18M
YoY Change	-122.13%	3234.65%
Pretax Income	$44.11M	-$42.08M
YoY Change	-204.83%	-328.47%
Income Tax	$10.69M	-$13.07M
% Of Pretax Income	24.23%
Net Earnings	$38.62M	-$28.38M
YoY Change	-236.06%	-305.01%
Net Earnings / Revenue	8.98%	-7.5%
Basic Earnings Per Share	$2.16	-$1.60
Diluted Earnings Per Share	$2.15	-$1.60
COMMON SHARES
Basic Shares Outstanding	17.79M shares	17.67M shares
Diluted Shares Outstanding	17.86M shares	17.67M shares

Balance Sheet

Concept	2021 Q1	2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$163.5M	$316.4M
YoY Change	-48.32%	339.44%
Cash & Equivalents	$163.5M	$316.4M
Short-Term Investments
Other Short-Term Assets	$48.30M	$43.00M
YoY Change	12.33%	133.7%
Inventory	$207.8M	$177.9M
Prepaid Expenses
Receivables	$411.5M	$357.9M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$831.0M	$895.2M
YoY Change	-7.17%	128.78%
LONG-TERM ASSETS
Property, Plant & Equipment	$195.8M	$202.1M
YoY Change	-3.12%	145.51%
Goodwill	$627.6M	$592.4M
YoY Change	5.94%	611.97%
Intangibles	$1.075B	$1.050B
YoY Change	2.39%	1579.76%
Long-Term Investments	$96.21M	$84.10M
YoY Change	14.4%	270.06%
Other Assets	$31.91M	$41.35M
YoY Change	-22.84%	28.66%
Total Long-Term Assets	$2.082B	$2.025B
YoY Change	2.79%	538.48%
TOTAL ASSETS
Total Short-Term Assets	$831.0M	$895.2M
Total Long-Term Assets	$2.082B	$2.025B
Total Assets	$2.913B	$2.921B
YoY Change	-0.26%	312.2%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$214.0M	$178.0M
YoY Change	20.25%	95.27%
Accrued Expenses	$45.50M	$50.10M
YoY Change	-9.18%	136.32%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$43.30M	$38.10M
YoY Change	13.65%	5342.86%
Total Short-Term Liabilities	$396.4M	$340.6M
YoY Change	16.4%	130.89%
LONG-TERM LIABILITIES
Long-Term Debt	$859.4M	$1.076B
YoY Change	-20.15%	9083.38%
Other Long-Term Liabilities	$141.6M	$150.3M
YoY Change	-5.79%	104.47%
Total Long-Term Liabilities	$859.4M	$1.076B
YoY Change	-20.15%	1162.85%
TOTAL LIABILITIES
Total Short-Term Liabilities	$396.4M	$340.6M
Total Long-Term Liabilities	$859.4M	$1.076B
Total Liabilities	$1.256B	$1.417B
YoY Change	-11.36%	440.46%
SHAREHOLDERS EQUITY
Retained Earnings	$455.5M	$377.4M
YoY Change	20.7%	-8.85%
Common Stock	$926.6M	$906.3M
YoY Change	2.24%	722.65%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.329B	$1.162B
YoY Change
Total Liabilities & Shareholders Equity	$2.913B	$2.921B
YoY Change	-0.26%	312.2%

Cashflow Statement

Concept	2021 Q1	2020 Q1
OPERATING ACTIVITIES
Net Income	$38.62M	-$28.38M
YoY Change	-236.06%	-305.01%
Depreciation, Depletion And Amortization	$22.15M	$21.20M
YoY Change	4.47%	336.24%
Cash From Operating Activities	-$12.62M	$20.22M
YoY Change	-162.41%	100995.0%
INVESTING ACTIVITIES
Capital Expenditures	$3.934M	$4.892M
YoY Change	-19.58%	92.83%
Acquisitions	$26.66M	$3.160M
YoY Change	743.51%	532.0%
Other Investing Activities	-$11.90M	-$3.100M
YoY Change	283.87%	675.0%
Cash From Investing Activities	-$15.85M	-$8.021M
YoY Change	97.54%	170.61%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net	$9.551M	$9.371M
YoY Change	1.92%
Cash From Financing Activities	$13.03M	$186.6M
YoY Change	-93.02%	-714.45%
NET CHANGE
Cash From Operating Activities	-$12.62M	$20.22M
Cash From Investing Activities	-$15.85M	-$8.021M
Cash From Financing Activities	$13.03M	$186.6M
Net Change In Cash	-$18.44M	$192.4M
YoY Change	-109.58%	-695.43%
FREE CASH FLOW
Cash From Operating Activities	-$12.62M	$20.22M
Capital Expenditures	$3.934M	$4.892M
Free Cash Flow	-$16.55M	$15.33M
YoY Change	-207.99%	-708.94%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q1	dei	Amendment Flag AmendmentFlag	false
CY2021Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2021Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000081362
CY2021Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	PA
CY2021Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2021Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2021Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2021Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021Q1	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	300000	USD
CY2020Q1	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	800000	USD
CY2021Q1	us-gaap	Decrease In Unrecognized Tax Benefits Is Reasonably Possible DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible	1500000	USD
CY2021Q1	kwr	Valuationallowanceamountrelatedtobusinesscombination Valuationallowanceamountrelatedtobusinesscombination	5500000	USD
CY2021Q1	dei	Entity Shell Company EntityShellCompany	false
CY2021Q1	dei	Document Type DocumentType	10-Q
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021Q1	dei	Entity File Number EntityFileNumber	001-12019
CY2021Q1	dei	Entity Registrant Name EntityRegistrantName	QUAKER CHEMICAL CORPORATION
CY2021Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	23-0993790
CY2021Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	901 E. Hector Street
CY2021Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Conshohocken
CY2021Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	PA
CY2021Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	19428 – 2380
CY2021Q1	dei	City Area Code CityAreaCode	610
CY2021Q1	dei	Local Phone Number LocalPhoneNumber	832-4000
CY2021Q1	dei	Security12b Title Security12bTitle	Common Stock, $1 par value
CY2021Q1	dei	Trading Symbol TradingSymbol	KWR
CY2021Q1	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2021Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2021Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	17873331	shares
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	429783000	USD
CY2020Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	378561000	USD
CY2021Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	273589000	USD
CY2020Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	244710000	USD
CY2021Q1	us-gaap	Gross Profit GrossProfit	156194000	USD
CY2020Q1	us-gaap	Gross Profit GrossProfit	133851000	USD
CY2021Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	104310000	USD
CY2020Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	98701000	USD
CY2021Q1	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0	USD
CY2020Q1	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	38000000	USD
CY2021Q1	us-gaap	Restructuring Charges RestructuringCharges	1175000	USD
CY2020Q1	us-gaap	Restructuring Charges RestructuringCharges	1716000	USD
CY2021Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	5815000	USD
CY2020Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	7878000	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	44894000	USD
CY2020Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-12444000	USD
CY2021Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	4687000	USD
CY2020Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-21175000	USD
CY2021Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-5470000	USD
CY2020Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-8461000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	44111000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10689000	USD
CY2021Q1	kwr	Income Loss From Continuing Operations Before Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeMinorityInterestAndIncomeLossFromEquityMethodInvestments	33422000	USD
CY2021Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	5210000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	38632000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-28344000	USD
CY2021Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	17000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	38615000	USD
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.16
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.15
CY2021Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.395
CY2020Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.385
CY2021Q1	us-gaap	Profit Loss ProfitLoss	38632000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-28344000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	562000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	-3981000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-26632000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	15000	USD
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-95000	USD
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	163455000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	181833000	USD
CY2021Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	411523000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	372974000	USD
CY2021Q1	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	97631000	USD
CY2020Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	86148000	USD
CY2021Q1	us-gaap	Inventory Finished Goods And Work In Process InventoryFinishedGoodsAndWorkInProcess	110147000	USD
CY2020Q4	us-gaap	Inventory Finished Goods And Work In Process InventoryFinishedGoodsAndWorkInProcess	101616000	USD
CY2021Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	48285000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	50156000	USD
CY2021Q1	us-gaap	Assets Current AssetsCurrent	831041000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	792727000	USD
CY2021Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	416514000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	423253000	USD
CY2021Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	220724000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	219370000	USD
CY2021Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	195790000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	203883000	USD
CY2021Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	38027000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	38507000	USD
CY2021Q1	us-gaap	Goodwill Goodwill	627574000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	631212000	USD
CY2021Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1075343000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1081358000	USD
CY2021Q1	us-gaap	Equity Method Investments EquityMethodInvestments	96213000	USD
CY2020Q4	us-gaap	Equity Method Investments EquityMethodInvestments	95785000	USD
CY2021Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	17057000	USD
CY2020Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	16566000	USD
CY2021Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	31906000	USD
CY2021Q1	us-gaap	Assets Assets	2912951000	USD
CY2021Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	104029000	USD
CY2020Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	93573000	USD
CY2021Q1	us-gaap	Liabilities Current LiabilitiesCurrent	396435000	USD
CY2021Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	859433000	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	849068000	USD
CY2020Q4	us-gaap	Assets Assets	2891834000	USD
CY2021Q1	us-gaap	Debt Current DebtCurrent	43330000	USD
CY2020Q4	us-gaap	Debt Current DebtCurrent	38967000	USD
CY2021Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	214015000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	198872000	USD
CY2021Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	29091000	USD
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	43300000	USD
CY2021Q1	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	5970000	USD
CY2020Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	8248000	USD
CY2021Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	27050000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	27070000	USD
CY2021Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	186031000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	192763000	USD
CY2021Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	1
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	1
CY2021Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000	shares
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000	shares
CY2021Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	17875076	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	17850616	shares
CY2021Q1	us-gaap	Common Stock Value CommonStockValue	17875000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	17851000	USD
CY2021Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	908748000	USD
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	905171000	USD
CY2021Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	455493000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	423940000	USD
CY2021Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-53228000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-26598000	USD
CY2020Q4	us-gaap	Minority Interest MinorityInterest	550000	USD
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1329453000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1320914000	USD
CY2021Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2912951000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2891834000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	38632000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-28344000	USD
CY2021Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1187000	USD
CY2020Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1187000	USD
CY2021Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	22145000	USD
CY2020Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	21197000	USD
CY2021Q1	us-gaap	Income Loss From Equity Method Investments Net Of Dividends Or Distributions IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions	5105000	USD
CY2020Q1	us-gaap	Income Loss From Equity Method Investments Net Of Dividends Or Distributions IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions	-4285000	USD
CY2021Q1	us-gaap	Business Combination Provisional Information Initial Accounting Incomplete Adjustment Inventory BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory	801000	USD
CY2020Q1	us-gaap	Business Combination Provisional Information Initial Accounting Incomplete Adjustment Inventory BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory	0	USD
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.60
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.60
CY2021Q1	kwr	Increase Decrease In Deferred Compensation And Other Net IncreaseDecreaseInDeferredCompensationAndOtherNet	-9888000	USD
CY2020Q1	kwr	Increase Decrease In Deferred Compensation And Other Net IncreaseDecreaseInDeferredCompensationAndOtherNet	-22988000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	3779000	USD
CY2020Q1	us-gaap	Share Based Compensation ShareBasedCompensation	4682000	USD
CY2021Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	5410000	USD
CY2020Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	2000	USD
CY2021Q1	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	0	USD
CY2020Q1	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	229000	USD
CY2021Q1	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0	USD
CY2020Q1	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	38000000	USD
CY2021Q1	kwr	Combination Related Expenses Net Of Payments CombinationRelatedExpensesNetOfPayments	-2884000	USD
CY2020Q1	kwr	Combination Related Expenses Net Of Payments CombinationRelatedExpensesNetOfPayments	-519000	USD
CY2021Q1	us-gaap	Restructuring Charges RestructuringCharges	1175000	USD
CY2020Q1	us-gaap	Restructuring Charges RestructuringCharges	1716000	USD
CY2021Q1	us-gaap	Pension And Other Postretirement Benefit Expense PensionAndOtherPostretirementBenefitExpense	-1034000	USD
CY2020Q1	us-gaap	Pension And Other Postretirement Benefit Expense PensionAndOtherPostretirementBenefitExpense	22453000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	46270000	USD
CY2020Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2322000	USD
CY2021Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	24994000	USD
CY2020Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	10162000	USD
CY2021Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	8315000	USD
CY2020Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3263000	USD
CY2021Q1	us-gaap	Increase Decrease In Restructuring Reserve IncreaseDecreaseInRestructuringReserve	-3034000	USD
CY2020Q1	us-gaap	Increase Decrease In Restructuring Reserve IncreaseDecreaseInRestructuringReserve	-4841000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	26597000	USD
CY2020Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-5275000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-12618000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	20219000	USD
CY2021Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3934000	USD
CY2020Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4892000	USD
CY2021Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	26655000	USD
CY2020Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	3160000	USD
CY2021Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	14744000	USD
CY2020Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
CY2021Q1	us-gaap	Proceeds From Insurance Settlement Investing Activities ProceedsFromInsuranceSettlementInvestingActivities	0	USD
CY2020Q1	us-gaap	Proceeds From Insurance Settlement Investing Activities ProceedsFromInsuranceSettlementInvestingActivities	31000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-15845000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-8021000	USD
CY2021Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	9551000	USD
CY2020Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	9371000	USD
CY2021Q1	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	30000000	USD
CY2020Q1	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	205500000	USD
CY2021Q1	us-gaap	Proceeds From Repayments Of Other Long Term Debt ProceedsFromRepaymentsOfOtherLongTermDebt	-188000	USD
CY2020Q1	us-gaap	Proceeds From Repayments Of Other Long Term Debt ProceedsFromRepaymentsOfOtherLongTermDebt	-185000	USD
CY2021Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	7052000	USD
CY2020Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	6828000	USD
CY2021Q1	us-gaap	Proceeds From Repurchase Of Equity ProceedsFromRepurchaseOfEquity	-178000	USD
CY2020Q1	us-gaap	Proceeds From Repurchase Of Equity ProceedsFromRepurchaseOfEquity	-696000	USD
CY2021Q1	us-gaap	Payments For Repurchase Of Redeemable Noncontrolling Interest PaymentsForRepurchaseOfRedeemableNoncontrollingInterest	0	USD
CY2020Q1	us-gaap	Payments For Repurchase Of Redeemable Noncontrolling Interest PaymentsForRepurchaseOfRedeemableNoncontrollingInterest	1047000	USD
CY2021Q1	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	0	USD
CY2020Q1	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	751000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	13031000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	186622000	USD
CY2021Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-3008000	USD
CY2020Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-6424000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-18440000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	192396000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	181895000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	143555000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	163455000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	335951000	USD
CY2021Q1	us-gaap	Number Of Countries In Which Entity Operates NumberOfCountriesInWhichEntityOperates	25	pure
CY2021Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	4	pure
CY2021Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	4	pure
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	429783000	USD
CY2020Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	378561000	USD
CY2021Q1	kwr	Operating Income Loss Segment Reporting OperatingIncomeLossSegmentReporting	109125000	USD
CY2020Q1	kwr	Operating Income Loss Segment Reporting OperatingIncomeLossSegmentReporting	87648000	USD
CY2021Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	5815000	USD
CY2020Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	7878000	USD
CY2021Q1	us-gaap	Restructuring Charges RestructuringCharges	1175000	USD
CY2020Q1	us-gaap	Restructuring Charges RestructuringCharges	1716000	USD
CY2021Q1	kwr	Fair Value Step Up Of Houghton Inventory Sold FairValueStepUpOfHoughtonInventorySold	801000	USD
CY2020Q1	kwr	Fair Value Step Up Of Houghton Inventory Sold FairValueStepUpOfHoughtonInventorySold	0	USD
CY2021Q1	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0	USD
CY2020Q1	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	38000000	USD
CY2021Q1	kwr	Nonoperating Charges NonoperatingCharges	40992000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	5194000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	4211000	USD
CY2020Q1	kwr	Nonoperating Charges NonoperatingCharges	38451000	USD
CY2021Q1	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	15448000	USD
CY2020Q1	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	14047000	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	44894000	USD
CY2020Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-12444000	USD
CY2021Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	4687000	USD
CY2020Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-21175000	USD
CY2021Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-5470000	USD
CY2020Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-8461000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	44111000	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-42080000	USD
CY2021Q1	kwr	Net Reporting Amount NetReportingAmount	17800000	USD
CY2020Q1	kwr	Net Reporting Amount NetReportingAmount	12500000	USD
CY2021Q1	us-gaap	Deferred Revenue DeferredRevenue	6300000	USD
CY2020Q4	us-gaap	Deferred Revenue DeferredRevenue	4000000.0	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	429783000	USD
CY2020Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	378561000	USD
CY2020Q1	kwr	Proceeds From Non Income Tax Refunds ProceedsFromNonIncomeTaxRefunds	1299000	USD
CY2021Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	3600000	USD
CY2020Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	3400000	USD
CY2021Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	300000	USD
CY2020Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	500000	USD
CY2021Q1	us-gaap	Variable Lease Cost VariableLeaseCost	0	USD
CY2021Q1	us-gaap	Sublease Income SubleaseIncome	0	USD
CY2020Q1	us-gaap	Variable Lease Cost VariableLeaseCost	0	USD
CY2020Q1	us-gaap	Sublease Income SubleaseIncome	0	USD
CY2021Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	3600000	USD
CY2020Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	3400000	USD
CY2021Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	3100000	USD
CY2021Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	38027000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	38507000	USD
CY2021Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	10419000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	10901000	USD
CY2021Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	27050000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	27070000	USD
CY2021Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	37469000	USD
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	37971000	USD
CY2021Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y10M24D
CY2020Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y
CY2021Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	4.26	pure
CY2020Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	4.20	pure
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	9269000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	9042000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	6932000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	8116000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	42764000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	5295000	USD
CY2021Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	37469000	USD
CY2021Q1	us-gaap	Restructuring And Related Cost Description RestructuringAndRelatedCostDescription	The Company’s management approved a global restructuring plan (the “QH Program”) as part of its plan to realize certain cost synergies associated with the Combination in the third quarter of 2019. The QH Program includes restructuring and associated severance costs to reduce total headcount by approximately 400 people globally, as well as plans for the closure of certain manufacturing and non-manufacturing facilities.
CY2021Q1	us-gaap	Restructuring And Related Cost Expected Number Of Positions Eliminated RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated	400	People
CY2020Q4	us-gaap	Restructuring Reserve RestructuringReserve	8248000	USD
CY2021Q1	us-gaap	Restructuring Charges RestructuringCharges	1175000	USD
CY2021Q1	us-gaap	Payments For Restructuring PaymentsForRestructuring	3034000	USD
CY2021Q1	us-gaap	Restructuring Reserve Translation Adjustment RestructuringReserveTranslationAdjustment	419000	USD
CY2021Q1	us-gaap	Restructuring Reserve RestructuringReserve	5970000	USD
CY2021Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3779000	USD
CY2020Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4682000	USD
CY2021Q1	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	5410000	USD
CY2020Q1	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	2000	USD
CY2021Q1	kwr	Proceeds From Non Income Tax Refunds ProceedsFromNonIncomeTaxRefunds	97000	USD
CY2021Q1	kwr	Pension And Post Retirement Benefit Costs Nonservice Components PensionAndPostRetirementBenefitCostsNonserviceComponents	-124000	USD
CY2020Q1	kwr	Pension And Post Retirement Benefit Costs Nonservice Components PensionAndPostRetirementBenefitCostsNonserviceComponents	23525000	USD
CY2021Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	195000	USD
CY2020Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-76000	USD
CY2021Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	4687000	USD
CY2020Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-21175000	USD
CY2021Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.242	pure
CY2020Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.311	pure
CY2021Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	339000	USD
CY2020Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	304000	USD
CY2021Q1	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-1478000	USD
CY2020Q1	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	821000	USD
CY2021Q1	kwr	Ustaxreformact Ustaxreformact	As of December 31, 2020, the Company had a deferred tax liability of $5.9 million, which primarily represents the Company’s estimate of non-U.S. taxes it will incur to repatriate certain foreign earnings to the U.S. The balance as of March 31, 2021 was $6.5 million.
CY2020Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	5900000	USD
CY2021Q1	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	6500000	USD
CY2021Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	23500000	USD
CY2020Q4	us-gaap	Decrease In Unrecognized Tax Benefits Is Reasonably Possible DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible	1300000	USD
CY2021Q1	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	100000	USD
CY2021Q1	us-gaap	Unrecognized Tax Benefits Income Tax Penalties Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense	100000	USD
CY2020Q1	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	100000	USD
CY2021Q1	kwr	Unrecognized Tax Benefits Income Tax Penalties Income UnrecognizedTaxBenefitsIncomeTaxPenaltiesIncome	3000000.0	USD
CY2021Q1	us-gaap	Unrecognized Tax Benefits Income Tax Penalties Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued	3600000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Accrued UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued	3000000.0	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued	3900000	USD
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17672525	shares
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.15
CY2020Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17855977	shares
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	38615000	USD
CY2020Q1	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	-101000	USD
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	38461000	USD
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17785370	shares
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17672525	shares
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.16
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	38615000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-28381000	USD
CY2021Q1	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted	154000	USD
CY2020Q1	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted	-101000	USD
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	38461000	USD
CY2020Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-28280000	USD
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17785370	shares
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17672525	shares
CY2021Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	70607	shares
CY2021Q1	us-gaap	Earnings Per Share Reconciliation Disclosure EarningsPerShareReconciliationDisclosure	Certain stock options and restricted stock units are not included in the diluted earnings (loss) per share calculation when the effect would have been anti-dilutive. The calculated amount of anti-diluted shares not included was 2,083 for the three months ended March 31, 2021. All of the Company’s potentially dilutive shares for the three months ended March 31, 2020 are anti-dilutive and not included in the dilutive loss per share calculations because of the Company’s net loss during the period.
CY2021Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2083	shares
CY2021Q1	us-gaap	Loss Contingency Settlement Agreement Terms LossContingencySettlementAgreementTerms	Prior to December 2020, the Company had restricted cash recorded in other assets related to proceeds from an inactive subsidiary of the Company which previously executed separate settlement and release agreements with two of its insurance carriers for an original total value of $35.0 million. The proceeds of both settlements were restricted and could only be used to pay claims and costs of defense associated with the subsidiary’s asbestos litigation. The proceeds of the settlement and release agreements were deposited into interest bearing accounts that earned less than $0.1 million offset by $0.2 million of net payments during the three months ended March 31, 2020.
CY2020Q1	us-gaap	Interest Income Other InterestIncomeOther	100000	USD
CY2020Q1	us-gaap	Loss Contingency Accrual Payments LossContingencyAccrualPayments	200000	USD
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	163455000	USD
CY2020Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	316437000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	181833000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	123524000	USD
CY2021Q1	us-gaap	Other Restricted Assets Current OtherRestrictedAssetsCurrent	0	USD
CY2020Q1	us-gaap	Other Restricted Assets Current OtherRestrictedAssetsCurrent	34000	USD
CY2020Q4	us-gaap	Other Restricted Assets Current OtherRestrictedAssetsCurrent	62000	USD
CY2019Q4	us-gaap	Other Restricted Assets Current OtherRestrictedAssetsCurrent	353000	USD
CY2021Q1	us-gaap	Restricted Cash RestrictedCash	0	USD
CY2020Q1	us-gaap	Restricted Cash RestrictedCash	19480000	USD
CY2020Q4	us-gaap	Restricted Cash RestrictedCash	0	USD
CY2019Q4	us-gaap	Restricted Cash RestrictedCash	19678000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	163455000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	335951000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	181895000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	143555000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	631212000	USD
CY2021Q1	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	5052000	USD
CY2021Q1	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-8690000	USD
CY2021Q1	us-gaap	Goodwill Goodwill	627574000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1019516000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1012371000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	149273000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	136113000	USD
CY2021Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	14800000	USD
CY2020Q1	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	38000000.0	USD
CY2020Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	14000000.0	USD
CY2021Q1	kwr	Finitelivedintangibleassetsamortizationexpensecurrentfiscalyear Finitelivedintangibleassetsamortizationexpensecurrentfiscalyear	59372000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	59096000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	58927000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	58427000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	57710000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	57484000	USD
CY2020Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	205100000	USD
CY2021Q1	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	205100000	USD
CY2021Q1	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	913087000	USD
CY2020Q4	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	899134000	USD
CY2021Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	10324000	USD
CY2020Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	11099000	USD
CY2021Q1	us-gaap	Other Long Term Debt Current OtherLongTermDebtCurrent	43330000	USD
CY2020Q4	us-gaap	Other Long Term Debt Current OtherLongTermDebtCurrent	38967000	USD
CY2021Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	859433000	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	849068000	USD
CY2021Q1	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	300000000.0	USD
CY2021Q1	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.016	pure
CY2021Q1	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	6000000	USD
CY2021Q1	us-gaap	Line Of Credit Facility Covenant Terms LineOfCreditFacilityCovenantTerms	The Company’s initial consolidated net debt to consolidated adjusted EBITDA ratio could not exceed 4.25 to 1, with step downs in the permitted ratio over the term of the Credit Facility. As of March 31, 2021, the consolidated net debt to adjusted EBITDA may not exceed 4.00 to 1. The Company’s consolidated adjusted EBITDA to interest expense ratio cannot be less than 3.0 to 1 over the term of the agreement. The Credit Facility also prohibits the payment of cash dividends if the Company is in default or if the amount of the dividend paid annually exceeds the greater of $50.0 million and 20% of consolidated adjusted EBITDA unless the ratio of consolidated net debt to consolidated adjusted EBITDA is less than 2.0 to 1, in which case there is no such limitation on amount.
CY2021Q1	us-gaap	Line Of Credit Facility Covenant Compliance LineOfCreditFacilityCovenantCompliance	As of March 31, 2021 and December 31, 2020, the Company was in compliance with all of the Credit Facility covenants
CY2021Q1	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	4650000	USD
CY2020Q1	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	7712000	USD
CY2021Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1187000	USD
CY2020Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1187000	USD
CY2021Q1	us-gaap	Interest Expense InterestExpense	5837000	USD
CY2020Q1	us-gaap	Interest Expense InterestExpense	8899000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1320914000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	38632000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-26632000	USD
CY2021Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.395
CY2021Q1	us-gaap	Dividends Common Stock DividendsCommonStock	7062000	USD
CY2021Q1	us-gaap	Stock Granted During Period Value Sharebased Compensation Gross StockGrantedDuringPeriodValueSharebasedCompensationGross	3601000	USD
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1329453000	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1242366000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-28344000	USD
CY2020Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.385
CY2020Q1	us-gaap	Noncontrolling Interest Increase From Sale Of Parent Equity Interest NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest	1047000	USD
CY2020Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	751000	USD
CY2020Q1	us-gaap	Stock Granted During Period Value Sharebased Compensation Gross StockGrantedDuringPeriodValueSharebasedCompensationGross	1039000	USD
CY2020Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1162541000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-26598000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Before Reclassifications Before Tax OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax	-24693000	USD
CY2021Q1	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax	-2223000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	-26916000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	286000	USD
CY2021Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-53228000	USD
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-78170000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Before Reclassifications Before Tax OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax	-61096000	USD
CY2020Q1	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax	24334000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	-36762000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	-6592000	USD
CY2020Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-121524000	USD
CY2021Q1	us-gaap	Cash Surrender Value Fair Value Disclosure CashSurrenderValueFairValueDisclosure	2015000	USD
CY2021Q1	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	2015000	USD
CY2020Q4	us-gaap	Cash Surrender Value Fair Value Disclosure CashSurrenderValueFairValueDisclosure	1961000	USD
CY2020Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	1961000	USD
CY2021Q1	us-gaap	Interest Rate Cash Flow Hedge Liability At Fair Value InterestRateCashFlowHedgeLiabilityAtFairValue	3943000	USD
CY2021Q1	us-gaap	Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet	3036000	USD
CY2020	us-gaap	Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet	3598000	USD

Files In Submission

Name	View Source	Status
0000081362-21-000008-index-headers.html	Edgar Link	pending
0000081362-21-000008-index.html	Edgar Link	pending
0000081362-21-000008.txt	Edgar Link	pending
0000081362-21-000008-xbrl.zip	Edgar Link	pending
exhibit101.htm	Edgar Link	pending
exhibit103.htm	Edgar Link	pending
exhibit104.htm	Edgar Link	pending
exhibit311.htm	Edgar Link	pending
exhibit312.htm	Edgar Link	pending
exhibit321.htm	Edgar Link	pending
exhibit322.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
kwr-20210331.xsd	Edgar Link	pending
kwr-2021033110q.htm	Edgar Link	pending
kwr-2021033110q_htm.xml	Edgar Link	completed
kwr-20210331_cal.xml	Edgar Link	unprocessable
kwr-20210331_def.xml	Edgar Link	unprocessable
kwr-20210331_lab.xml	Edgar Link	unprocessable
kwr-20210331_pre.xml	Edgar Link	unprocessable
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$KWR
QUAKER CHEMICAL CORP Stock $kwr

2021 Q1 Form 10-Q Financial Statement

#000008136221000008 Filed on May 06, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KWR QUAKER CHEMICAL CORP Stock $kwr

2021 Q1 Form 10-Q Financial Statement

#000008136221000008 Filed on May 06, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KWR
QUAKER CHEMICAL CORP Stock $kwr